Vaccine Market By Technology Type (Recombinant, Conjugate Vaccines, Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, and Other), Indication (Pneumococcal Disease, Influenza, Human Papilloma Virus, Meningococcal Disease, Rotavirus, Varicella, Measles, Mumps, & Rubella, Diphtheria, Pertussis, & Tetanus, Polio, Hepatitis and Other) and End User (Pediatric, Adult and Traveler) and Geography – Global Forecast up to 2027

  • July, 2021
  • Domain: Healthcare - Pharmaceuticals
Pages: 91
Tables: 73
Charts: 103
Regions/Countries: 4 / 10
Companies: 10
Enquiry Hours: 10
  • Get Free 10% Customization in this Report

Vaccines, also known as immunizations, administered a weakened form of a disease into a person’s body, so the body starts producing antibodies or immunity against the disease. Adequate immunization has destroyed several diseases, such as polio and smallpox, with high death rates. Vaccinations play a vital role in maintaining the sustainable health of people among various countries; hence, they are adopted in various regional disease-prevention strategies. High incidence of diseases requiring vaccines and increasing use of vaccines for several infectious diseases, such as influenza, pneumonia, and rotavirus infection, are projected to significantly accelerate the global vaccines market's growth. In addition, the focus of governments on immunization programs helps promote awareness among people regarding the safety and availability of vaccines. Further, various technologies deployed in the development of effective vaccines foster the vaccine market growth. However, the high monetary inputs incurred in the vaccine development decline their adoption, thus impeding the market growth. The Vaccines Market is estimated to grow at the rate of 6.7% CAGR by 2027.  

Research Methodology:

The Vaccine Market has been analyzed by utilizing the optimum combination of secondary sources and in-house methodology and a unique balance of primary insights. The real-time valuation of the market is an integral part of our forecasting and market sizing methodology. Industry experts and our primary participants have helped to compile related aspects with accurate parametric estimations for a complete study. The primary participants share is given below:

Vaccines Market

Vaccines Market based on Technology Type

  • Recombinant
  • Conjugate Vaccines
  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines
  • Others

Vaccines Market based on Indication

  • Pneumococcal Disease
  • Influenza
  • Human Papilloma Virus
  • Meningococcal Disease
  • Rotavirus
  • Varicella, Measles, Mumps, & Rubella
  • Diphtheria, Pertussis, & Tetanus
  • Polio
  • Hepatitis
  • Other

Vaccines Market based on End-User

  • Pediatric
  • Adults
  • Travelers

Vaccines Market based on Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

On the basis of technology type, the conjugate vaccine segment has the primary share in the market. This is due to the rising government support along with the increasing company investments in conjugate vaccine development. In addition, conjugate vaccines are the most effective type of immunization, used to avoid diseases in both infants and adults, fueling the segment growth.

The market is further segmented based on the indication, in which diphtheria, pertussis, & tetanus segment hold a significant share in the market. The foremost share of this segment is attributed to the increasing number of cases of these diseases because of the increasing geriatric population and an increasing number of birth rates where these diseases are most likely to affect.

As per the market by end-user, the market is bifurcated into pediatrics, adults, and travelers. The pediatric segment has held a substantial share in the market, owing to the huge demand for vaccines among infants such as MMR vaccines, BCG vaccines, and DPT vaccines since infants are more prone to diseases where vaccines are mainly required.

According to the geographical market, the market is divided into North America, Europe, Asia Pacific, and the rest of the world. The North American region is registered for the largest share in the market. This is due to the high incidence of infectious diseases and rising investments by government and non-government organizations for vaccine development in the region.

In the present era, there are growing concerns about the spread of infectious diseases with the changing environment worldwide. These rising infectious diseases are pressure on public health but also affect global economies. The new diseases such as HIV, hepatitis, dengue have drawn considerable concern for the government of the respective countries. There is also an upturn of diseases assumed to be under control, such as malaria, cholera, and many more. Thus the rising number of dreadful infectious diseases and upturn of the diseases are creating a major growth in the vaccines market.

This report includes the company profiles of the Panacea Biotec Limited, Johnson & Johnson Services, Inc, VBI Vaccines Inc., Merck & Co., Inc., Astellas Pharma Inc., GlaxoSmithKline Plc, Sanofi S.A., PFIZER INC, NOVAVAX, INC., and Bavarian Nordic.

As a result, vaccines have emerged as an effective solution for the rising infectious diseases worldwide. Various governments of several countries are substantially investing in developing effective vaccines for a surging number of diseases worldwide.

  • Several factors are presented in this report which are influencing the market growth and limiting the market.
  • This report covers the segmentation and sub-segmentations and their contribution to the market's growth.
  • The report includes profiles of the key competitors in the vaccine market and their strategies such as product launches, company expansions, and acquisitions.
  • Further, the penetration of the market in the various countries is also depicted in this report.
  1. Executive Summary
  2. Industry Outlook
    1. Industry Overview
    2. Industry Trends
  3. Market Snapshot
    1. Market Definition
    2. Market Outlook
      1. Porter Five Forces
    3. Related Markets
  4. Market characteristics
    1. Market Overview
    2. Market Segmentation
    3. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
    4. DRO - Impact Analysis
  5. Technology Type: Market Size & Analysis
    1. Overview
    2. Recombinant
    3. Conjugate Vaccines
    4. Live Attenuated Vaccines
    5. Inactivated Vaccines
    6. Toxoid Vaccines
    7. Others
  6. Indication: Market Size & Analysis
    1. Overview
    2. Pneumococcal Disease
    3. Influenza
    4. Human Papilloma Virus
    5. Meningococcal Disease
    6. Rotavirus
    7. Varicella, Measles, Mumps, & Rubella
    8. Diphtheria, Pertussis, & Tetanus
    9. Polio
    10. Hepatitis
    11. Other
  7. End-User: Market Size & Analysis
    1. Overview
    2. Pediatric
    3. Adults
    4. Travelers
  8. Geography: Market Size & Analysis
    1. Overview
    2. North America
    3. Europe
    4. Asia Pacific
    5. Rest of the World
  9. Competitive Landscape
    1. Competitor Comparison Analysis
    2. Market Developments
      1. Mergers and Acquisitions, Legal, Awards, Partnerships
      2. Product Launches and execution
  10. Vendor Profiles
    1. Panacea Biotec Limited
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    2. Johnson & Johnson Services, Inc
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    3. VBI Vaccines Inc.
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    4. Merck & Co., Inc.
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    5. Astellas Pharma Inc.
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    6. GlaxoSmithKline Plc
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    7. Sanofi S.A.
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    9. NOVAVAX, INC.
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    10. Bavarian Nordic
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
  11. Analyst Opinion
  12. Annexure
    1. Report Scope
    2. Market Definitions
    3. Research Methodology
      1. Data Collation and In-house Estimation
      2. Market Triangulation
      3. Forecasting
    4. Report Assumptions
    5. Declarations
    6. Stakeholders
    7. Abbreviations

Research Framework

Infoholic research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:

  • Data Collation (Primary & Secondary)
  • In-house Estimation (Based on proprietary data bases and Models)
  • Market Triangulation
  • Forecasting

Market related information is congregated from both primary and secondary sources.

Primary sources

involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.

Secondary sources

include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.

Interested in this report?
Get your FREE sample now!

Select User License


Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer 10% worth of FREE customization at the time of purchase